CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Fecal Microbiota Transplantation for Autism: Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Last updated: June 13, 2019
Project Number: RB1353-000
Product Line: Rapid Response
Research Type: Devices and Systems
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of fecal microbiota transplantation for the treatment of individuals with autism spectrum disorder?
  2. What is the cost-effectiveness of fecal microbiota transplantation for the treatment of individuals with autism spectrum disorder?
  3. What are the evidence-based guidelines regarding the use of fecal microbiota transplantation for the treatment of individuals with autism spectrum disorder?

Key Message

No relevant literature was identified regarding fecal microbiota transplantation for the treatment of individuals with autism spectrum disorder.